Concepedia

HOTAIR‐EZH2 inhibitor AC1Q3QWB upregulates CWF19L1 and enhances cell cycle inhibition of CDK4/6 inhibitor palbociclib in glioma

Shi Jin, Shigang Lv, Miaojing Wu, Xianggan Wang, Yan Deng, Yansheng Li, Kuanxun Li, Hongyu Zhao, Xingen Zhu, Minhua Ye

Clinical and Translational Medicine · 2020 · 36 citations · 28 references

DOIFull text

Open access

Abstract

The combination of AQB and CDK4/6 inhibitor palbociclib has been found to have significant antitumor effects, which is likely to become a new strategy for glioma treatment.

References

28

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21K citations · Full text

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Nicholas C. Turner, Jungsil Ro, Fabrice André et al. · New England Journal of Medicine · 2015 · 1.5K citations · Full text

Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts

David W. Fry, Patricia J. Harvey, Paul R. Keller et al. · Molecular Cancer Therapeutics · 2004 · 1.2K citations

CBP-mediated acetylation of histone H3 lysine 27 antagonizes<i>Drosophila</i>Polycomb silencing

Feng Tie, Rakhee Banerjee, Carl A. Stratton et al. · Development · 2009 · 559 citations · Full text

, , +19

The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.

Frank B. Furnari, Hongyi Huang, Webster K. Cavenee · PubMed · 1998 · 400 citations

, , +17